Compounds and compositions as c-kit and PDGFR kinase inhibitors
申请人:IRM LLC
公开号:US08338417B2
公开(公告)日:2012-12-25
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFR and PDGFR kinases.